Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 20,262

Document Document Title
WO/2018/070641A2
The present invention relates to a compound represented by chemical formula 1 for an organic optoelectronic element, an organic optoelectronic element employing the same, and a display device. The details for chemical formula 1 above are...  
WO/2018/071327A1
This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Arthropoda, Mollusca, and Nematoda, processes to produce such molecules, intermediates used in such processes, pesticidal compositions con...  
WO/2018/067423A1
Compounds of general formula (la), compounds of general formula (la'), compounds of general formula (lb), compounds of general formula (lb'), compounds of general formula (I), compounds of general formula (Ι'), and their pharmaceuticall...  
WO/2018/065611A1
The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain 2-amino-N-(arylsulfinyl)- acetamide compounds that, inter alia, inhibit (e.g., selectively inhibi...  
WO/2018/066783A1
The present invention relates to a composition for an organic optoelectronic element, the composition comprising: a first host compound represented by chemical formula 1 below; and a second host compound represented by chemical formula 2...  
WO/2018/066646A1
The present invention addresses the problem of finding a novel medicine which has an excellent tryptophanase inhibitory effect, suppresses indoxyl sulfate production in blood to thereby prevent deterioration of renal function, and thus c...  
WO/2018/060916A1
The present invention relates to process for preparation of Brexpiprazole of formula-l and intermediates thereof. The present invention is further directed to process for the preparation of anhydrous form of Brexpiprazole, pharmaceutical...  
WO/2018/056649A1
Disclosed is a compound represented by chemical formula (1). In addition, disclosed is an organic electronic element comprising: a first electrode; a second electrode; and an organic layer between the first electrode and the second elect...  
WO/2018/056658A1
Disclosed is a compound represented by chemical formula (1). In addition, disclosed is an organic electronic element comprising: a first electrode; a second electrode; and an organic layer between the first electrode and the second elect...  
WO/2018/053643A1
Described herein are compositions and methods for modulating cellular senescence of a cell or induction of the senescence-associated secretory phenotype (SASP) in a cell. The methods generally comprise modulating the level or activity of...  
WO/2018/051252A2
An object of the present invention is to provide an amide compound or a salt thereof that controls a mite. The present invention provides an amide compound represented by Formula (1) : or a salt thereof, wherein R1 represents C1-6 alkyl ...  
WO/2018/045149A1
Disclosed are compounds of Formula (I), Formula (II), Formula (III), and Formula (IV) or salts thereof, wherein R2 is -OH or -OP(O)(OH)2; and R1 is defined herein. Also disclosed are methods of using such compounds as selective agonists ...  
WO/2018/039376A1
The present invention relates to monoterpenoid and phenylpropanoid containing derivative compounds, methods of making the compounds, compositions comprising the compounds, and methods of repelling pests using the compounds and/or composi...  
WO/2018/038400A1
The present invention relates to a novel compound and an organic electroluminescence device including same. The compound according to the present invention may be used in an organic material layer, preferably, a light emitting layer, of ...  
WO/2018/033642A1
The present invention relates to a compound of formula (I): wherein L is an optionally substituted heterocyclic group excluding unsubstituted monocyclic pyridine groups; wherein a is 0, 1 or 2; wherein R1 is H or with R2 is a bond; where...  
WO/2018/034883A1
The invention provides compounds of the formula: (A), pharmaceutically acceptable salts, pharmaceutical compositions thereof, and methods of using these compounds, salts, or compositions to treat hyperphosphatemia, chronic kidney disease...  
WO/2018/035172A1
Provided herein are compounds, including enantiomerically pure forms thereof, and pharmaceutically acceptable salts or co-crystals and prodrugs thereof which have glucagon receptor antagonist or inverse agonist activity. Further, provide...  
WO/2018/034702A1
Disclosed are alpha-axyl-beta-axmno isoquinoline amide compounds and substituted benzamide compounds. In particular, the invention provides compounds that affect the function of kinases in a cell and that are useful as therapeutic agents...  
WO/2018/028461A1
Disclosed are a novel cationic photoinitiator, and a preparation method therefor and applications thereof. The cationic photoinitiator has a structure represented by formula (I), can match a longer absorption wavelength in the applicatio...  
WO/2018/028557A1
The present invention relates to a series of tricyclic compounds and the use thereof as receptor agonists of 1-phosphate sphingosine 1 subtype (S1P1), and in particular to the compounds shown in formula (I), and tautomers or pharmaceutic...  
WO/2018/020974A1
Provided are the following: a sulfonium salt which does not contain a toxic metal and which exhibits higher cationic polymerization performance and crosslinking performance than a tetrakis(pentafluorophenyl)borate salt; a heat- or photo-...  
WO/2018/018863A1
Disclosed are a mild and efficient preparation method for an α-acyloxy alkenyl amide compound and a use thereof in the synthesis of an amide and a polypeptide. The α-acyloxy alkenyl amide compound is obtained by an addition reaction of...  
WO/2018/019291A1
Provided is a method of synthesizing a C(sp3)-C(sp2) cross-coupled compound comprising reacting a C(sp3) coupling partner with a C(sp2) coupling partner, a catalyst, and a solvent; wherein the C(sp3) coupling partner comprises an organic...  
WO/2018/018091A1
The present invention relates to compounds and their use in the prophylactic and/or therapeutic treatment of pulmonary fibrosis and/or related conditions.  
WO/2018/021663A1
The present invention relates to a composition for an organic optoelectronic element, an organic optoelectronic element employing the composition, and a display device, wherein the composition comprises: a first compound for an organic o...  
WO/2018/019436A1
The present invention relates to a process for preparing a partially hydrogenated polyacene, and a novel intermediate used in such process; also the present invention relates to a process for preparing the corresponding conjugated polyac...  
WO/2018/014277A1
The present invention relates to a rotigotine behenate and a manufacturing method and application thereof, and provides a method for manufacturing the rotigotine behenate and an application of the rotigotine behenate in treating a diseas...  
WO/2018/016786A1
The present invention provides: a compound capable of implementing high luminous efficiency, a low driving voltage and improved lifespan of a device; an organic electronic device using the same; and an electronic apparatus thereof.  
WO/2018/016898A1
The present invention provides a novel heterocyclic compound and an organic light-emitting device using same.  
WO/2018/016742A1
The present invention provides a novel heterocyclic compound and an organic light-emitting device using same.  
WO/2018/016354A1
The present disclosure provides an organic compound represented by general formula 1. In general formula 1: a partial structure Z1 represents a condensed polycyclic group optionally containing a nitrogen atom in the skeleton and containi...  
WO/2018/014820A1
Provided are a fluorescent dye and a preparation method and use thereof. The fluorescent dye has the ability to emit a long wavelength, is sensitive and specific to a viscosity response, can be used for a viscosity test, and can also be ...  
WO/2018/016611A1
Provided is a novel therapeutic agent for glaucoma, which has an sGC-activating activity. A therapeutic agent for glaucoma or an ocular hypotensive agent, which contains, as an active ingredient, a compound represented by formula (I-a) o...  
WO/2018/007479A1
The invention relates to novel organic semiconducting compounds containing a polycyclic unit, to methods for their preparation and educts or intermediates used therein, to compositions, polymer blends and formulations containing them, to...  
WO/2018/008737A1
The present invention addresses the problem of providing a compound which exerts its effect on the onset mechanism of Parkinson's disease by inhibiting the degeneration and cell death of dopamine-secreting cells, and a therapeutic or pro...  
WO/2018/004095A1
The present invention relates to a compound, for an organic optoelectronic device, expressed by chemical formula (1), a composition for an organic optoelectronic device, an organic optoelectronic device having applied same, and a display...  
WO/2018/004187A1
The present invention provides a novel compound capable of improving light-emitting efficiency, stability, and life span of an element, an organic electrical element using the same, and an electronic device therefor.  
WO/2018/004096A1
The present invention relates to a compound, for an organic optoelectronic device, expressed by chemical formula (1), a composition for an organic optoelectronic device, an organic optoelectronic device having applied same, and a display...  
WO/2017/220925A1
The invention relates to a method for preparing substituted thiolactones of formula (I), new substituted thiolactones of formula (I') that can be obtained by carrying out said method, and the use of substituted thiolactones of formula (I...  
WO/2017/221780A1
Provided is a photoelectric conversion element having superior durability against irradiation with light. The photoelectric conversion element has a cathode, an anode, an active layer provided between the cathode and the anode and contai...  
WO/2017/223407A1
The present invention is a conjugated polymer that contains both Unit (I) and Unit (II) is shown below: X, in each occurrence, is independently selected from S or Se. M1 and M2 are independently selected from H or F. R1 and R2 are indepe...  
WO/2017/217553A1
[Problem] To provide a novel agricultural chemical, and particularly an herbicide. [Solution] An oxime compound represented by formula (1) and an herbicide containing the same. (In formula (1): B represents B-1 or the like; Q represents ...  
WO/2017/217676A1
The present invention relates to a novel compound having excellent thermal stability and luminescent ability, and an organic electroluminescent element having enhanced characteristics such as luminous efficiency, driving voltage, and lif...  
WO/2017/216661A1
The present invention relates to a process for the preparation of 7-{4-[4-(1-benzothiophen-4-yl)piperazin-1-yl]butoxy} quinolin-2(1H)-one (brexpiprazole) from 7-(4-chlorobutoxy)quinolin-2(1H)-one and 1-(benzo[b]thiophen-4-yl)piperazine. ...  
WO/2017/215549A1
Disclosed are an organic electroluminescent compound and an application thereof. The structural formula of the compound is as shown in general formula (1). The material has good fluorescence quantum efficiency and electroluminescence eff...  
WO/2017/209294A1
According to the present invention, it is possible to safely and easily obtain sulfonimidized aromatic compounds using various substrates and a novel sulfonimidization agent by irradiating, with light in the presence of an oxidizer, a co...  
WO/2017/208965A1
The present invention provides an organic compound characterized by being represented by general formula [1] set forth in the claims. In general formula [1], Ar1 and Ar2 are each independently selected from among aryl groups having 6-18 ...  
WO/2017/207596A1
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices, which comprise these compounds.  
WO/2017/208251A1
The present invention relates to a new crystalline polymorph of brexpiprazole. More specifically, the invention relates to novel Form M of brexpiprazole, process for preparing the novel form of brexpiprazole and pharmaceutical formulatio...  
WO/2017/209322A1
The present invention relates to a five-membered heterocyclic compound having an analgesic effect and a pharmaceutical composition comprising a derivative of the five-membered heterocyclic compound. More specifically, the present inventi...  

Matches 1 - 50 out of 20,262